EXCELLOS, Inc — Form D
EXCELLOS, Inc of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-24. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-11-24
- Form: D
- Accession: 0001895465-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $15.0M
- Investors: 1
- Date of first sale: 2021-11-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-422431
Issuer
- Name: EXCELLOS, Inc
- CIK: 0001895465
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1155 ISLAND AVE, SUITE 250, SAN DIEGO, CA, 92101
- Phone: 858-472-8732
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Paul Grossman | Director | San Diego, CA |
| Alex Herzik | Director | San Diego, CA |
| Deval Lashkari | Director | San Francisco, CA |
| Terance Kinninger | Director | SAN DIEGO, CA |
| Deval Lashkari, Ph.D. | Director | SAN DIEGO, CA |
| David Wellis, Ph.D. | Director | SAN DIEGO, CA |
| David Wellis, Ph.D. | Executive Officer | SAN DIEGO, CA |
| Robert Finzi | Director | SAN DIEGO, CA |
| Paul Grossman, Ph.D. | Director | SAN DIEGO, CA |
Other filings by this issuer (1)
More